Concepedia

André Elferink

AE

Statistics

Publications

6

Citations

221

H-Index

6

Active since

2004

Affiliations

Medicines Evaluation Board(Current)

Federal Institute for Drugs and Medical Devices

European Medicines Agency

Medical University of Warsaw

André Elferink is an author at Medicines Evaluation Board specializing in medicine, pharmacotherapy, and psychopharmacology.

Publications per year

2004–2023

6

Publications

6

European regulators’ views on a wearable-derived performance measurement of ambulation for Duchenne muscular dystrophy regulatory trials

Marion Haberkamp, Jane Moseley, Dimitrios Athanasiou et al. · Neuromuscular Disorders · 2019 · 72 citations · Full text

, , +15

Response to Tricyclic Antidepressants: Independent of Gender?

Tamar Wohlfarth, Jitschak G. Storosum, André Elferink et al. · American Journal of Psychiatry · 2004 · 52 citations

, , +16

Insomnia medication: Do published studies reflect the complete picture of efficacy and safety?

Taina Mattila, Violeta Stoyanova, André Elferink et al. · European Neuropsychopharmacology · 2010 · 32 citations

, , +14

The therapeutic potential of psychedelics: the European regulatory perspective

Florence Butlen‐Ducuing, Drummond E-Wen McCulloch, Marion Haberkamp et al. · The Lancet · 2023 · 27 citations

, , +14

Interchangeability of generic anti-epileptic drugs: a quantitative analysis of topiramate and gabapentin

Marc Maliepaard, Nikola Banishki, Christine C. Gispen‐de Wied et al. · European Journal of Clinical Pharmacology · 2011 · 26 citations

, , +8

1–5 of 6